This CEU Statement provides guidance to healthcare professionals in response to a letter circulated by MSD (manufacturer of Nexplanon®) to healthcare professionals in the UK about updated guidance regarding the recommended Nexplanon® insertion site.
The statement states that the FSRH opt to support MSD in their recommendation to adjust the implant site. In the statement, FSRH highlight that:
- regardless of insertion site, it is critical to ensure that deep insertion is avoided
- care must be taken to identify anatomical landmarks correctly so that insertion into the sulcus between
biceps and triceps is avoided
- Nexplanon insertion (and removal) should only be carried out by appropriately trained healthcare
professionals. The manufacturer has produced materials to clarify the recommended insertion site and technique and to support those who have been trained to insert Nexplanon at a different site. FSRH will be producing further training materials. FSRH-trained Nexplanon inserters trained to insert Nexplanon over biceps may choose to continue to do so until they are competent and confident in identifying the new insertion site, ensuring as always that insertion is superficial and avoids the sulcus
- Nexplanon implants that are already in situ at another site should not be removed and replaced at this recommended site unless routine replacement is due.
To read the full statement, click here >